share_log

Marpai | 10-Q: Quarterly report

Marpai | 10-Q: Quarterly report

Marpai | 10-Q:季度報表
美股SEC公告 ·  08/08 05:27
牛牛AI助理已提取核心訊息
Marpai, Inc. (Marpai), a technology-driven healthcare third-party administrator, reported its financial performance for the quarter ended June 30, 2024. The company experienced a decrease in revenue to $7.2 million, down 28.4% from $10.0 million in the same quarter of the previous year. Operating loss widened to $12.3 million, a 68.8% increase from the prior year's $7.3 million. Net loss for the quarter was $13.0 million, compared to $7.6 million in the previous year, with a loss per share of $1.23. For the six-month period, revenue was $14.6 million, a 26.1% decrease from $19.7 million in the prior year, and net loss was $17.4 million, up from $16.4 million. The company recognized an impairment of goodwill and intangible assets amounting to $7.6 million. Marpai's business development includes the integration of two TPA companies...Show More
Marpai, Inc. (Marpai), a technology-driven healthcare third-party administrator, reported its financial performance for the quarter ended June 30, 2024. The company experienced a decrease in revenue to $7.2 million, down 28.4% from $10.0 million in the same quarter of the previous year. Operating loss widened to $12.3 million, a 68.8% increase from the prior year's $7.3 million. Net loss for the quarter was $13.0 million, compared to $7.6 million in the previous year, with a loss per share of $1.23. For the six-month period, revenue was $14.6 million, a 26.1% decrease from $19.7 million in the prior year, and net loss was $17.4 million, up from $16.4 million. The company recognized an impairment of goodwill and intangible assets amounting to $7.6 million. Marpai's business development includes the integration of two TPA companies and the elimination of non-value added services and development projects. The company is exploring strategic alternatives to maximize shareholder value, which may include a merger or sale. Marpai's financial statements have raised substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $94.1 million and negative working capital of $1.5 million. The company's future plans involve raising additional capital or securing debt funding to support ongoing operations until it achieves cash self-sufficiency.
科技驅動的醫療第三方管理公司Marpai公司報告了截至2024年6月30日的財務業績。公司營業收入下降至720萬美元,較上一年同期的1000萬美元下降了28.4%。營業虧損擴大至1230萬美元,比上年增長了68.8%的730萬美元。本季度淨虧損爲1300萬美元,而上一年的淨虧損爲760萬美元,每股虧損爲1.23美元。前六個月的營業收入爲1460萬美元,較上一年的1970萬美元下降了26.1%;淨虧損爲1740萬美元,而上一年爲1640萬美元。公司確認了760萬美元的商譽和無形資產減值。 Marpai業務發展包括整合兩家TPA公司和取消無價值的服務和開發項目。公司正在探索戰略選擇,以最大程度地提高股東價值,其中可能包括合併或出售。Marpai的基本報表引發了對其作爲持續經營者的能力的嚴重質疑,累計赤字達9410萬美元,負營運資本達150萬美元。公司的未來計劃包括籌集額外資本或獲得債務融資來支持運營,直到實現現金自給自足。
科技驅動的醫療第三方管理公司Marpai公司報告了截至2024年6月30日的財務業績。公司營業收入下降至720萬美元,較上一年同期的1000萬美元下降了28.4%。營業虧損擴大至1230萬美元,比上年增長了68.8%的730萬美元。本季度淨虧損爲1300萬美元,而上一年的淨虧損爲760萬美元,每股虧損爲1.23美元。前六個月的營業收入爲1460萬美元,較上一年的1970萬美元下降了26.1%;淨虧損爲1740萬美元,而上一年爲1640萬美元。公司確認了760萬美元的商譽和無形資產減值。 Marpai業務發展包括整合兩家TPA公司和取消無價值的服務和開發項目。公司正在探索戰略選擇,以最大程度地提高股東價值,其中可能包括合併或出售。Marpai的基本報表引發了對其作爲持續經營者的能力的嚴重質疑,累計赤字達9410萬美元,負營運資本達150萬美元。公司的未來計劃包括籌集額外資本或獲得債務融資來支持運營,直到實現現金自給自足。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。